Marksans Pharma announced that a current Good Manufacturing Practice (cGMP) inspection was conducted by the US FDA at the 2nd manufacturing facility of the Company located at Plot No. A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa, India from 3rd November 2025 to
7th November 2025.
The said inspection concluded with Zero Form 483 observation.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
